Rax Health Care Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 17-07-2024
- Paid Up Capital ₹ 1.64 M
as on 17-07-2024
- Company Age 28 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.00 M
as on 17-07-2024
- Satisfied Charges ₹ 2.50 M
as on 17-07-2024
- Revenue -15.05%
(FY 2023)
- Profit -43.15%
(FY 2023)
- Ebitda -35.03%
(FY 2023)
- Net Worth 8.17%
(FY 2023)
- Total Assets 22.15%
(FY 2023)
About Rax Health Care
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.64 M.
The company currently has active open charges totaling ₹7.00 M. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rajat Tayal, Reshu Tayal, and Yogesh Tayal serve as directors at the Company.
- CIN/LLPIN
U24232UP1996PTC020928
- Company No.
020928
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Oct 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rax Health Care Private Limited offer?
Rax Health Care Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Hand Sanitizer & Disinfectant, Hand Sanitizer Spray, Vitamin Tablets & Capsules, Vitamin C Tablets & Capsules, Ayurvedic Medicine, Calcium Tablet, Calcium & Vitamin D3 Tablet, Antipyretic Medication.
Who are the key members and board of directors at Rax Health Care?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajat Tayal  | Director | 28-Mar-2011 | Current |
| Reshu Tayal | Director | 25-May-2016 | Current |
| Yogesh Tayal | Director | 31-Oct-1996 | Current |
Financial Performance of Rax Health Care.
Rax Health Care Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.05% decrease. The company also saw a substantial fall in profitability, with a 43.15% decrease in profit. The company's net worth moved up by a moderate rise of 8.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rax Health Care?
In 2022, Rax Health Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Feb 2010 | ₹7.00 M | Open |
Indiabulls Housing Finance Limited Creation Date: 13 Aug 2014 | ₹2.50 M | Satisfied |
How Many Employees Work at Rax Health Care?
Unlock and access historical data on people associated with Rax Health Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rax Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rax Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
